Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neuphoria Therapeutics (NEUP) EBT Margin (2024 - 2025)

Historic EBT Margin for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q2 2025 value amounting to 116256.64%.

  • Neuphoria Therapeutics' EBT Margin changed N/A to 116256.64% in Q2 2025 from the same period last year, while for Dec 2025 it was 82.44%, marking a year-over-year change of. This contributed to the annual value of 45.44% for FY2025, which is N/A changed from last year.
  • As of Q2 2025, Neuphoria Therapeutics' EBT Margin stood at 116256.64%.
  • In the past 5 years, Neuphoria Therapeutics' EBT Margin ranged from a high of 116256.64% in Q2 2025 and a low of 291.49% during Q4 2024